Mutations of the interferon sensitivity-determining region (ISDR) correlate with the complexity of hypervariable region (HVR)-1 in the Japanese variant of hepatitis C virus (HCV) type 1b

Journal of Medical Virology

Volumn 74, Issue 1, 2004, Pages 54-61

  Nakano, Isao ^a   Fukuda, Yoshihide ^a   Katano, Yoshiaki ^a   Toyoda, Hidenori ^a   Hayashi, Kazuhiko ^a   Kumada, Takashi ^b   Nakano, Satoshi ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OGAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

E1; E2; J type; NS5A; Subtype measurement; W type

Indexed keywords

INTERFERON; RIBAVIRIN;

ADULT; AGE; ARTICLE; CHRONIC HEPATITIS; CLINICAL ARTICLE; CORRELATION FUNCTION; FEMALE; GENETIC VARIABILITY; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; JAPAN; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENETIC TREE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIDE EFFECT; VIRUS LOAD; VIRUS MUTATION;

ANTIVIRAL AGENTS; BASE SEQUENCE; DRUG RESISTANCE, VIRAL; FEMALE; GENES, VIRAL; GENOTYPE; HEPACIVIRUS; HUMANS; INTERFERONS; JAPAN; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; SEQUENCE ALIGNMENT; SEQUENCE HOMOLOGY; VARIATION (GENETICS); VIRAL ENVELOPE PROTEINS; VIRAL NONSTRUCTURAL PROTEINS;

HEPATITIS C VIRUS; HEPATITIS C VIRUS TYPE 1; HEPATITIS C VIRUS TYPE 1B;

EID: 3342891283     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20145     Document Type: Article

References (20)

1. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Izumi N, Marumo F, Sato C. 1995. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b-sensitivity to interferon is conferred by amino acid substitutions in the NS5A region. J Clin Invest 96:224-230.
2. Enomoto N, Sakuma I, Asahina Y, Kurosaki M, Murakami T, Yamamoto C, Ogura Y, Izumi N, Marumo F, Sato C. 1996. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection. N Engl J Med 334:77-81.
3. Farci P, Shimoda A, Coiana A, Diaz G, Peddis G, Melpolder JC, Strazzera A, Chien DY, Munoz SJ, Balestrieri A, Purcell RH, Alter HJ. 2000. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288:339-344.
4. Hino K, Yamahuchi Y, Fujiwara D, Katoh Y, Korenaga M, Okazaki M, Okuda M, Okita K. 2000. Hepatitis C virus quasispecies and response to interferon therapy in patients with chronic hepatitis C: A prospective study. J Viral Hepatitis 7:36-42.
5. Izopet J, Rostaing L, Sandres K, Cisterne JM, Pasquier C, Rumeau JL, Duffaut M, Durand D, Puel J. 2000. Longitudinal analysis of hepatitis C virus replication and liver fibrosis progression in renal transplant recipients. J Infect Dis 181:852-858.
6. Khorsi H, Castelain S, Wyseur A, Izopet J, Canva V, Rombout A, Capron D, Capron JP, Lunel F, Stuyver L, Duverlie G. 1997. Mutations of hepatitis C virus 1b NS5A 2209-2248 amino acid sequence do not predict the response to recombinant interferon-alfa therapy in French patients. J Hepatology 27:72-77.
7. Koizumi K, Enomoto N, Kurosaki M, Murakami T, Izumi N, Marumo F, Sato C. 1995. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment. Hepatology 22:30-35.
8. Lyra AC, Fan X, Lang DM, Yusim K, Ramrakhiani S, Brunt EM, Korber B, Perelson AS, Di Bisceglie AM. 2002. Evolution of hepatits C viral quasispecies after liver transplantation. Gastroenterology 123:1729-1733.
9. Nakano I, Fukuda Y, Katano Y, Nakano S, Kumada T, Hayakawa T. 1999. Why is the interferon sensitivity-determining region (ISDR) system useful in Japan? J Hepatol 30:1014-1022.
10. Nakano I, Fukuda Y, Katano Y, Toyoda H, Hayashi K, Hayakawa T, Kumada T, Nakano S. 2001a. Interferon responsiveness in patients infected with hepatitis C virus 1b differs depending on viral subtype. Gut 49:263-267.
11. Nakano I, Fukuda Y, Katano Y, Toyoda H, Hayashi K, Kumada T, Nakano S. 2001b. Japan-specific subtype of hepatitis C virus genotype 1b, J subtype, has relatively low pathogenicity. J Med Virol 65:45-51.
12. Noguchi T, Satoh S, Noshi T, Hatada E, Fukuda R, Kawai A, Ikeda S, Hijikata M, Shimotohno K. 2001. Effects of mutation in hepatitis C virus nonstructural protein 5A on interferon resistance mediated by inhibition of PKR kinase activity in mammalian cells. Microbiol Immunol 45:829-840.
13. Otagiri H, Fukuda Y, Nakano I, Katano Y, Toyoda H, Yokozaki S, Hayashi K, Hayakawa T, Fukuda Y, Kinoshita M, Takamatsu J. 2002. Evaluation of a new assay for hepatitis C virus genotyping and viral load determination in patients with chronic hepatitis C. J Virol Methods 103:137-143.
14. Poynard T, Yuen MF, Ratziu V, Lai CL. 2003. Viral hepatitis C. Lancet 362:2095-2100.
15. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P. 1997. The origin of hepatitis C virus genotypes. J Gen Virol 78:321-328.
16. Taniguchi S, Okamoto H, Sakamoto M, Kojima M, Tsuda F, Tanaka T, Munekata E, Muchmore EE, Peterson DA, Mishiro S. 1993. A structurally flexible and antigenically variable N-terminal domain of hepatitis C virus E2/NS1 protein: Implication for an escape from antibody. Virology 195:297-301.
17. Toyoda H, Fukuda Y, Koyama Y, Nakano I, Kinoshita M, Hadama T, Takamatsu J, Hayakawa T. 1996. Nucleotide sequence diversity of hypervariable region 1 of hepatitis C virus in Japanese hemophiliacs with chronic hepatitis C and patients with chronic posttransfusion hepatitis C. Blood 88:1488-1493.
18. Vrolijk JM, Bekkering FC, Brouwer JT, Hansen BE, Schalm SW. 2003. High sustained virological response in chronic hepatitis C by combining induction and prolonged maintenance therapy. J Viral Hepat 10:205-209.
19. Yeh BI, Han KH, Lee HW, Sohn JH, Ryu WS, Yoon DJ, Yoon J, Kim HW, Kong ID, Chang SJ, Choi JW. 2002. Factors predictive of response to interferon-alpha therapy in hepatitis C virus type 1b infection. J Med Virol 66:481-487.
20. Zeuzem S, Lee JH, Roth WK. 1997. Mutations in the nonstructural 5A gene of European hepatitis C virus isolates and response to interferon alfa. Hepatology 25:740-744.